6 studies found for:    ct-p13
Show Display Options
Rank Status Study
1 Completed An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1
Condition: Ankylosing Spondylitis
Intervention: Biological: Infliximab
2 Completed An Extension Study to Demonstrate Long-Term Efficacy and Safety of CT-P13 When Co-administered With Methotrexate in Patient With Rheumatoid Arthritis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 3.1
Condition: Rheumatoid Arthritis
Intervention: Biological: Infliximab
3 Recruiting Demonstrate Noninferiority in Efficacy and to Assess Safety of CT-P13 in Patients With Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Biological: CT-P13;   Biological: Remicade
4 Completed Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)
Condition: Ankylosing Spondylitis
Intervention: Drug: Infliximab
5 Completed Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)
Condition: Rheumatoid Arthritis
Intervention: Drug: Infliximab
6 Not yet recruiting The NOR-SWITCH Study
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Ulcerative Colitis;   Crohn's Disease;   Psoriasis Chronic
Interventions: Drug: Innovator infliximab;   Drug: Biosimilar infliximab

Indicates status has not been verified in more than two years